Content
@
0 reply
0 recast
0 reaction
James
@jamesp
The OpenAI of Longevity... Before OpenAI launched ChatGPT, Sam Altman invested all his networth in two companies. One of them, Retro Biosciences, is a longevity company He was their sole investor, putting $180m in. Apparently talks to the CEO every weekend. They aim for therapeutics in patients by end of decade
1 reply
0 recast
3 reactions
Omar
@dromar.eth
Interesting that both Sam and Brian Armstrong (NewLimit) have longevity companies they're building out. Great to see them investing in the space.
1 reply
0 recast
1 reaction